96 related articles for article (PubMed ID: 17434369)
1. The surgical management of rectal cancer: a comparison of treatment methods and outcomes over 2 time periods in the same geographic region.
Orrom WJ; Hayashi AH; Kuechler D; Ross AC; Kuechler PM; Larsson S; Rusnak CH; Weinerman B
Am J Surg; 2007 May; 193(5):623-6; discussion 626. PubMed ID: 17434369
[TBL] [Abstract][Full Text] [Related]
2. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
3. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
4. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer].
Wu AW; Gu J; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):207-9. PubMed ID: 16721678
[TBL] [Abstract][Full Text] [Related]
5. Results after change of treatment policy for rectal cancer--report from a single hospital in China.
Wu AW; Gu J; Wang J; Ye SW; An Q; Yao YF; Zhan TC
Eur J Surg Oncol; 2007 Aug; 33(6):718-23. PubMed ID: 17240113
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ
Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295
[TBL] [Abstract][Full Text] [Related]
7. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
8. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
Wiig JN; Larsen SG; Dueland S; Giercksky KE
Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
[TBL] [Abstract][Full Text] [Related]
9. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
Pugliese R; Di Lernia S; Sansonna F; Scandroglio I; Maggioni D; Ferrari GC; Costanzi A; Magistro C; De Carli S
Am J Surg; 2008 Feb; 195(2):233-8. PubMed ID: 18083137
[TBL] [Abstract][Full Text] [Related]
10. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery.
Rutten H; den Dulk M; Lemmens V; Nieuwenhuijzen G; Krijnen P; Jansen-Landheer M; van de Poll Franse L; Coebergh JW; Martijn H; Marijnen C; van de Velde C
Eur J Cancer; 2007 Oct; 43(15):2295-300. PubMed ID: 17709242
[TBL] [Abstract][Full Text] [Related]
11. Impact of radiotherapy on local recurrence of rectal cancer in Norway.
Hansen MH; Kjaeve J; Revhaug A; Eriksen MT; Wibe A; Vonen B;
Br J Surg; 2007 Jan; 94(1):113-8. PubMed ID: 17083107
[TBL] [Abstract][Full Text] [Related]
12. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence.
Kusters M; Beets GL; van de Velde CJ; Beets-Tan RG; Marijnen CA; Rutten HJ; Putter H; Moriya Y
Ann Surg; 2009 Feb; 249(2):229-35. PubMed ID: 19212175
[TBL] [Abstract][Full Text] [Related]
13. Operative safety and oncologic outcomes of anal sphincter-preserving surgery with mesorectal excision for rectal cancer: 931 consecutive patients treated at a single institution.
Kim NK; Kim YW; Min BS; Lee KY; Sohn SK; Cho CH
Ann Surg Oncol; 2009 Apr; 16(4):900-9. PubMed ID: 19198951
[TBL] [Abstract][Full Text] [Related]
14. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.
Vermaas M; Gosselink MP; Ferenschild FT; van den Aardweg E; Lont HE; Kemperman HW; van der Harst E; Tetteroo GW; Oostenbroek RJ; Dijkhuis CM; Eggermont AM; de Wilt JH
Eur J Surg Oncol; 2007 Sep; 33(7):862-7. PubMed ID: 17257804
[TBL] [Abstract][Full Text] [Related]
15. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
16. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
17. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
18. [Factors affecting the prognosis and selection of local excision for low rectal cancer].
Hang JW; Zhou ZX; Bu YQ; Bai XF; Wang X; Zhao P
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):141-3. PubMed ID: 17645854
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic versus open surgery for rectal cancer: long-term oncologic results.
Laurent C; Leblanc F; Wütrich P; Scheffler M; Rullier E
Ann Surg; 2009 Jul; 250(1):54-61. PubMed ID: 19561481
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy for stage IIIA rectal cancer: is it justified?
Kariv Y; Kariv R; Hammel JP; Lavery IC
Dis Colon Rectum; 2008 Oct; 51(10):1459-66. PubMed ID: 18661186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
